Clinical Trials Browser

Pancreatic Neoplasms

Advanced Rectal Cancer

Gastrointestinal Neoplasms

Locally Advanced Gastric Cancer

Rectal Neoplasms

Esophageal Neoplasms

Colonic Neoplasms

Colorectal Cancer Metastatic

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Pancreatic Neoplasms

Pancreatic Neoplasms

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Cervical Esophagus Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Elderly Metastatic Colorectal Cancer Patients

Stomach Neoplasms

Rectal Neoplasms

Neoplasms, Pancreatic Neoplasms

Rectal Neoplasms

Rectal Cancer Patients

Esophageal Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Locally Advanced Rectal Cancer

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Locally Advanced Colorectal Cancer

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Clinical Trials

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

K-BOOST

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

OPTICAL

TriComB

GRECCAR12

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Neo-CD

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

MAIBE

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

JS212 Combination Therapies in Metastatic Colorectal Cancer

LAP100

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

TNTIT

CLEAR-01

CLEAR-02

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

CASINOs

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

EC-CRT-008

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

COBRA

T-DXd_HER2Low

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

LyRICX

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

Toco-CoR

TORCH-iTNT

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

COLOCROSS